Skip to main content

Blog

Honoring Every Journey in Duchenne and Becker: Advancing Therapies, Access, and Care For All

...

Capricor Therapeutics Announces Positive Topline Results from HOPE-3 Study of Deramiocel

...

A Thanksgiving Message from Pat

...

Watch the Recording: Avidity Biosciences – EXPLORE44-OLE® Topline and Functional Data Presentation

...

PPMD Launches New Study to Understand Patient and Caregiver Treatment Preferences

...

Sarepta Announces FDA Approval to Begin ENDEAVOR Cohort 8 Dosing in Non-Ambulatory Individuals Living with Duchenne

...

Closing Out the Year with Connection & Community at PPMD Together

...

Avidity Biosciences Announces U.S. Managed Access Program for del-zota

...

Becker Muscular Dystrophy Series – Part 2: Cardiopulmonary Care

...

FDA Approves New Safety Warning and Revised Indication for ELEVIDYS

...